danone glp-1 North America GLP-1 Users' Guide to Protein

It is also virtually calorie free, with just 10% of the calories of sugar, making it a great tool for weight management

only Q&A sessions are restricted to paying subscribers

Baseline liver enzyme assessment is reasonable for patients with: Pre-existing liver disease or elevated baseline transaminases Metabolic syndrome or clinical features suggesting MASLD Concurrent use of other potentially hepatotoxic medications Obesity (BMI 30 kg/m) with additional metabolic risk factors History of excessive alcohol consumption For patients with abnormal baseline liver enzymes, periodic monitoring every 3-6 months during the first year of therapy allows clinicians to assess treatment response and detect any unexpected changes

Well, to begin with, the populations weight is going up

Potential Benefits The use of compounded GLP-1 medications for weight management is not FDA-approved

GLP-1 Receptor Agonists: Promising Therapeutic Targets for Alcohol Use Disorder